Subtopic Deep Dive
Anxiety in Coronary Heart Disease
Research Guide
What is Anxiety in Coronary Heart Disease?
Anxiety in Coronary Heart Disease examines the independent risk of anxiety for adverse cardiac events in CHD patients, measured via tools like HADS, and evaluates treatment trials addressing anxiety-depression comorbidity and autonomic pathways.
Research shows anxiety independently predicts cardiac events in CHD populations beyond depression (Rozanski et al., 1999). Studies highlight comorbidity with depression and autonomic mechanisms linking anxiety to arrhythmias. Over 20 key papers, including guidelines, address screening and management, with European guidelines citing psychosocial risks (Perk et al., 2012; 8493 citations).
Why It Matters
Anxiety screening in CHD improves risk stratification, as psychosocial factors like anxiety contribute to CAD pathogenesis and worse outcomes (Rozanski et al., 1999; 2835 citations). Guidelines recommend addressing anxiety in prevention strategies to reduce mortality (Perk et al., 2012; Visseren et al., 2021). In clinical practice, treating anxiety enhances holistic care, reducing recurrence in post-MI patients (Hare et al., 2013).
Key Research Challenges
Distinguishing Anxiety from Depression
Anxiety often co-occurs with depression in CHD, complicating independent risk assessment (Rozanski et al., 1999). HADS scales measure both, but overlap reduces specificity. Trials struggle to isolate anxiety effects (Hare et al., 2013).
Measuring Autonomic Pathways
Anxiety links to arrhythmias via autonomic dysregulation, but causal pathways remain unclear (Rozanski et al., 1999). Few studies quantify heart rate variability in anxious CHD patients. Longitudinal data gaps persist (Perk et al., 2012).
Conducting Treatment Trials
Randomized trials for anxiety interventions in CHD show mixed results due to small samples and high dropout. CBT and SSRIs lack CHD-specific efficacy data (Visseren et al., 2021). Comorbidity confounds outcomes (Luppino et al., 2010).
Essential Papers
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Joep Perk, Guy De Backer, H. Gohlke et al. · 2012 · European Heart Journal · 8.5K citations
peer reviewed
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · 2021 · European Heart Journal · 5.7K citations
International audience
Overweight, Obesity, and Depression
Floriana S. Luppino, Leonore de Wit, Paul F. Bouvy et al. · 2010 · Archives of General Psychiatry · 4.2K citations
This meta-analysis confirms a reciprocal link between depression and obesity. Obesity was found to increase the risk of depression, most pronounced among Americans and for clinically diagnosed depr...
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
Alan Rozanski, James A. Blumenthal, Jay R. Kaplan · 1999 · Circulation · 2.8K citations
Abstract —Recent studies provide clear and convincing evidence that psychosocial factors contribute significantly to the pathogenesis and expression of coronary artery disease (CAD). This evidence ...
Depression in Late Life: Review and Commentary
Dan G. Blazer · 2003 · The Journals of Gerontology Series A · 2.3K citations
Depression is perhaps the most frequent cause of emotional suffering in later life and significantly decreases quality of life in older adults. In recent years, the literature on late-life depressi...
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll, Marco Solmi, Nicola Veronese et al. · 2017 · World Psychiatry · 1.6K citations
People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta‐analysis is lacki...
Depression and cardiovascular disease: a clinical review
David L. Hare, Samia R. Toukhsati, Peter Johansson et al. · 2013 · European Heart Journal · 1.3K citations
Cardiovascular disease (CVD) and depression are common. Patients with CVD have more depression than the general population. Persons with depression are more likely to eventually develop CVD and als...
Reading Guide
Foundational Papers
Start with Rozanski et al. (1999; Circulation, 2835 citations) for psychosocial CAD mechanisms, then Perk et al. (2012; 8493 citations) for screening guidelines, followed by Hare et al. (2013) for clinical depression-CVD links.
Recent Advances
Study Visseren et al. (2021; European Heart Journal, 5688 citations) for updated prevention including mental health, and Correll et al. (2017) for SMI-CVD mortality risks.
Core Methods
HADS for anxiety screening; meta-analyses for risk pooling (Luppino et al., 2010); heart rate variability for autonomic assessment (Rozanski et al., 1999).
How PapersFlow Helps You Research Anxiety in Coronary Heart Disease
Discover & Search
Research Agent uses searchPapers and citationGraph on 'anxiety coronary heart disease' to map 50+ papers from Rozanski et al. (1999; 2835 citations), revealing clusters around psychosocial risks. exaSearch finds guideline updates like Visseren et al. (2021), while findSimilarPapers expands to HADS validation studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract HADS anxiety scores from Rozanski et al. (1999), then verifyResponse with CoVe checks claims against Perk et al. (2012). runPythonAnalysis performs meta-regression on prevalence data via pandas, with GRADE grading psychosocial evidence as moderate quality.
Synthesize & Write
Synthesis Agent detects gaps in anxiety-specific trials versus depression-focused ones (Hare et al., 2013), flagging contradictions in risk pathways. Writing Agent uses latexEditText, latexSyncCitations for guideline summaries, and latexCompile to generate formatted reviews with exportMermaid for comorbidity flowcharts.
Use Cases
"Run meta-analysis on anxiety prevalence in CHD cohorts using paper data."
Research Agent → searchPapers('anxiety HADS CHD') → Analysis Agent → runPythonAnalysis(pandas aggregate prevalence from 10 papers) → CSV export of pooled ORs with confidence intervals.
"Draft LaTeX review on anxiety treatment trials in post-MI patients."
Synthesis Agent → gap detection in trials → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Perk 2012, Visseren 2021) → latexCompile(PDF review with tables).
"Find code for heart rate variability analysis in anxious CHD patients."
Research Agent → paperExtractUrls('HRV anxiety CHD') → Code Discovery → paperFindGithubRepo → githubRepoInspect(extracts Python HRV scripts) → runPythonAnalysis(test on sample data).
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(100 papers on anxiety-CHD) → citationGraph → GRADE grading → structured report on risks (Rozanski 1999). DeepScan applies 7-step analysis with CoVe checkpoints to verify autonomic pathway claims from Hare et al. (2013). Theorizer generates hypotheses on anxiety-arrhythmia links from guideline data (Perk 2012).
Frequently Asked Questions
What defines anxiety in coronary heart disease?
Anxiety in CHD is excessive worry predicting adverse events independently of depression, measured by HADS-A subscale (Rozanski et al., 1999).
What methods assess anxiety risk in CHD?
HADS and State-Trait Anxiety Inventory screen anxiety; guidelines recommend routine use in CVD prevention (Perk et al., 2012; Visseren et al., 2021).
What are key papers on this topic?
Rozanski et al. (1999; Circulation, 2835 citations) links psychosocial factors to CAD; Perk et al. (2012; 8493 citations) provides prevention guidelines; Hare et al. (2013) reviews depression-CVD overlap.
What open problems exist?
Lack of large RCTs for anxiety-specific interventions in CHD; unclear autonomic mechanisms; need for better comorbidity disentanglement (Visseren et al., 2021).
Research Cardiac Health and Mental Health with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Anxiety in Coronary Heart Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiac Health and Mental Health Research Guide